Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined Administration of (R)-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism
Anna Rafało-Ulińska, Piotr Brański, Agnieszka Pałucha-Poniewiera
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 125-125
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review
Dmitry Frank, Benjamin F. Gruenbaum, Alexander Zlotnik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15114-15114
Open Access | Times Cited: 77
The antidepressant actions of ketamine and its enantiomers
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108431-108431
Open Access | Times Cited: 73
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 49
cAMP-PKA cascade: An outdated topic for depression?
Feng Gao, Shaojie Yang, Juan Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113030-113030
Open Access | Times Cited: 54
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 35
Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications
Senbing Zhang, Yanzhu Pu, Jianning Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development
Shigeyuki Chaki, Mai Watanabe
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1451-1462
Closed Access | Times Cited: 16
TrkB receptor interacts with mGlu 2 receptor and mediates antipsychotic-like effects of mGlu 2 receptor activation in the mouse
Clementine Philibert, Candice Disdier, Pierre‐André Lafon, et al.
Science Advances (2024) Vol. 10, Iss. 4
Open Access | Times Cited: 5
Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice
Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Michał Santocki, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 3, pp. 504-518
Closed Access | Times Cited: 5
(R)-ketamine induces mGlu5 receptor-dependent antidepressant-like effects in the chronic unpredictable mild stress model of depression in mice
Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Agata Faron‐Górecka, et al.
Psychopharmacology (2025)
Open Access
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of (R)-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 288-288
Open Access | Times Cited: 9
Hippocampal miR-124 Participates in the Pathogenesis of Depression via Regulating the Expression of BDNF in a Chronic Social Defeat Stress Model of Depression
Lin-Sheng Shi, Chun-Hui Ji, Wenqian Tang, et al.
Current Neurovascular Research (2022) Vol. 19, Iss. 2, pp. 210-218
Closed Access | Times Cited: 13
New investigational agents for the treatment of major depressive disorder
Bartłomiej Pochwat, Anna Julia Krupa, Marcin Siwek, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 1053-1066
Closed Access | Times Cited: 13
Ketamine, benzoate, and sarcosine for treating depression
Yu‐Jung Cheng, Chieh‐Hsin Lin, Hsien‐Yuan Lane
Neuropharmacology (2022) Vol. 223, pp. 109351-109351
Closed Access | Times Cited: 13
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions
Anna Onisiforou, Polymnia Georgiou, Panos Zanos
Pharmacology Biochemistry and Behavior (2023) Vol. 223, pp. 173531-173531
Closed Access | Times Cited: 8
Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation
Yana Babii, Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 1001-1011
Open Access | Times Cited: 2
Antidepressant-like effects of Rehmannioside A on rats induced by chronic unpredictable mild stress through inhibition of endoplasmic reticulum stress and apoptosis of hippocampus
Mei Yuan, Bozhi Yuan
Journal of Chemical Neuroanatomy (2022) Vol. 125, pp. 102157-102157
Closed Access | Times Cited: 11
Suppressive Effects of Isofraxidin on Depressive-like Behaviors Induced by Chronic Unpredictable Mild Stress in Mice
Xiaoli Wu, Jingwen Gu, Zhicong Zou, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1376-1376
Open Access | Times Cited: 11
The role of mGlu2/3 receptor antagonists in the enhancement of the antidepressant-like effect of ketamine
Agnieszka Pałucha-Poniewiera
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173454-173454
Open Access | Times Cited: 8
Partial mGlu5 Receptor NAM, M-5MPEP, Induces Rapid and Sustained Antidepressant-like Effects in the BDNF-dependent Mechanism and Enhances (R)-Ketamine Action in Mice
Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Michał Santocki, et al.
(2024)
Open Access | Times Cited: 1
Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus
Carlos Arrabal-Gómez, Pedro Jesús Serrano Castro, Jose Andrés Sánchez‐Pérez, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 4, pp. 309-322
Open Access | Times Cited: 1
Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons
Francisco de Borja Belloch, M. Cortés-Erice, Étienne Herzog, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110640-110640
Closed Access | Times Cited: 6
Metabotropic Glutamate Receptor 2 Expression Is Chronically Elevated in Male Rats With Post-Traumatic Stress Disorder Related Behavioral Traits Following Repetitive Low-Level Blast Exposure
Rita De Gasperi, Miguel A. Gama Sosa, Georgina Perez Garcia, et al.
Journal of Neurotrauma (2023) Vol. 41, Iss. 5-6, pp. 714-733
Closed Access | Times Cited: 3
Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
Caitlyn J. Bartsch, Jacob C. Nordman
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 5
Effect of Cryptotanshinone on BDNF/TrkB Pathway in Hippocampus of Chronic Stress-induced Depression Rats
Shaomei Lin, Shuifa Wu, Wanting Liao, et al.
Pharmacognosy Magazine (2024) Vol. 20, Iss. 3, pp. 956-964
Open Access
Page 1 - Next Page

Scroll to top